Novartis AG (CHIX:NOVNz)
CHF 87.96 -0.78 (-0.88%) Market Cap: 177.46 Bil Enterprise Value: 193.40 Bil PE Ratio: 11.84 PB Ratio: 4.80 GF Score: 56/100

Novartis AG Webinar: Integrating ESG Into Strategy Transcript

Nov 12, 2021 / 02:00PM GMT
Katrina Lucking

So good afternoon and good morning. A very warm welcome here to the Novartis lecture on integrating ESG into strategy. It gives me great pleasure to introduce my 2 guests for today. First of all, let me introduce you to Professor George Serafeim. Professor Serafeim is the Charles M. Williams Professor of Business Administration and the faculty chair of the Impact-Weighted Accounts at Harvard Business School. He has presented his research in over 60 countries around the world, including to world leaders and events such as the World Economic Forum.

He ranks among the top 10 most popular authors out of over 12,000 business authors on the Social Science Research Network. And he is currently teaching the course "Risks, Opportunities and Investments in an Era of Climate Change" that he designed for the elective curriculum in the MBA program at Harvard. Welcome, George.

And to my second guest, Dr. Lutz Hegemann. Dr. Hegemann is the Group Head of Corporate Affairs and Global Health at Novartis. Lutz started his career as a public health physician and scientist, and currently is

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot